Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization.

Solbach TF, Grube M, Fromm MF, Zolk O.

J Cardiovasc Pharmacol. 2011 Oct;58(4):409-17. doi: 10.1097/FJC.0b013e3182270783.

PMID:
21697722
2.

Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.

Zolk O, Solbach TF, König J, Fromm MF.

Drug Metab Dispos. 2009 Jun;37(6):1312-8. doi: 10.1124/dmd.108.023762. Epub 2009 Feb 27.

PMID:
19251820
3.

Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).

Zolk O, Solbach TF, König J, Fromm MF.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):337-48. doi: 10.1007/s00210-008-0369-5. Epub 2008 Nov 11.

PMID:
19002438
4.

Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure.

Zolk O, Solbach TF, Eschenhagen T, Weidemann A, Fromm MF.

Biochem Biophys Res Commun. 2008 Nov 14;376(2):315-20. doi: 10.1016/j.bbrc.2008.08.152. Epub 2008 Sep 7.

PMID:
18782560
5.

ATP-binding cassette transporters in human heart failure.

Solbach TF, Paulus B, Weyand M, Eschenhagen T, Zolk O, Fromm MF.

Naunyn Schmiedebergs Arch Pharmacol. 2008 May;377(3):231-43. doi: 10.1007/s00210-008-0279-6. Epub 2008 Apr 8.

PMID:
18392808
6.

ATP-binding cassette transporters in the heart.

Solbach TF, König J, Fromm MF, Zolk O.

Trends Cardiovasc Med. 2006 Jan;16(1):7-15. Review.

PMID:
16387624

Supplemental Content

Loading ...
Support Center